# Effect of Digital Self-Monitoring on Patient Engagement and Clinical Outcomes in Severe Asthma: A Randomized Controlled Pilot Study

**Authors:** Norbert Wellmann, Versavia Maria Ancusa, Monica Steluta Marc, Ana Adriana Trusculescu, Ioana Ciortea, Flavia Gabriela Martis, Pescaru Andrei, Andreea Roxana Durdan, Ovidiu Fira-Mladinescu

PMC · DOI: 10.3390/medicina62020368 · 2026-02-12

## TL;DR

A pilot study found that weekly reminders improved adherence and satisfaction in severe asthma patients using a digital monitoring system, but had no significant impact on lung function.

## Contribution

This study demonstrates the feasibility and acceptability of telemedicine-based home monitoring with reminders for severe asthma management.

## Key findings

- Adherence to home monitoring was significantly higher in the reminder group compared to the control group.
- Patients in the reminder group reported higher satisfaction and perceived educational benefits.
- No significant differences in lung function parameters were observed between the groups.

## Abstract

Background and Objectives: Severe asthma poses significant clinical and economic burdens, with adherence to monitoring and treatment remaining a challenge despite biologic therapies. This pilot study aimed to evaluate the feasibility of telemedicine-based home monitoring using the AioCare system in patients with severe asthma and to determine if weekly reminder messages improved adherence compared to standard monitoring. Materials and Methods: In this prospective, single-center randomized controlled pilot study, 30 adults with severe asthma were assigned to either a reminder group (weekly SMS or in-app messages) or a control group without reminders. All participants performed weekly home spirometry for 12 weeks using the AioCare system. Lung function parameters, Asthma Control Test (ACT) scores, adherence to monitoring, and patient satisfaction were assessed. Longitudinal data were analyzed using mixed-effects and generalized estimating equation models. Results: Adherence to home monitoring was significantly higher in the reminder group (11.47 ± 0.92 vs. 9.13 ± 3.16 sessions; p = 0.044). Overall, patient satisfaction was higher in the intervention group (p = 0.0044), with universal endorsement of the reminders and perceived educational benefit. No significant between-group differences were observed in lung function parameters. ACT scores showed a favorable trend in both groups, with a medium between-group effect size favoring the intervention (d = 0.42), although this did not reach statistical significance. Conclusions: Home monitoring with reminders is feasible, safe, and enhances adherence and satisfaction in severe asthma, although it did not significantly affect short-term changes in lung function or symptom control. Larger, longer-term studies are warranted to determine whether these engagement benefits translate into improved long-term clinical outcomes.

## Linked entities

- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, TSLP (thymic stromal lymphopoietin) [NCBI Gene 85480], IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}
- **Diseases:** airway inflammation (MESH:D007249), injuries (MESH:D014947), respiratory disease (MESH:D012140), psychiatric (MESH:D001523), pulmonary conditions (MESH:D008171), Asthma (MESH:D001249), obstructive respiratory condition (MESH:D012131), COPD (MESH:D029424), airway disorders (MESH:D000402), bronchiectasis (MESH:D001987), interstitial lung disease (MESH:D017563), cognitive impairment (MESH:D003072), Infectious Diseases (MESH:D003141)
- **Chemicals:** oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941848/full.md

---
Source: https://tomesphere.com/paper/PMC12941848